Therapeutic advances in the targeting of ROR1 in hematological cancers.

MLA

Tigu, Adrian-Bogdan, et al. “Therapeutic Advances in the Targeting of ROR1 in Hematological Cancers.” Cell Death Discovery, vol. 10, no. 1, Nov. 2024, p. 471. EBSCOhost, https://doi.org/10.1038/s41420-024-02239-1.

APA

Tigu, A.-B., Munteanu, R., Moldovan, C., Rares, D., Kegyes, D., Tomai, R., Moisoiu, V., Ghiaur, G., Tomuleasa, C., Einsele, H., Gulei, D., & Croce, C. M. (2024). Therapeutic advances in the targeting of ROR1 in hematological cancers. Cell Death Discovery, 10(1), 471. https://doi.org/10.1038/s41420-024-02239-1

Chicago

Tigu, Adrian-Bogdan, Raluca Munteanu, Cristian Moldovan, Drula Rares, David Kegyes, Radu Tomai, Vlad Moisoiu, et al. 2024. “Therapeutic Advances in the Targeting of ROR1 in Hematological Cancers.” Cell Death Discovery 10 (1): 471. doi:10.1038/s41420-024-02239-1.